Princeton Global Asset Management’s Novo Nordisk NVO Stock Holding History

Princeton Global Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.4K	Sell	1,573 -734	-32%	-$31.5K	0.01%	321
2026 Q1	$84.8K	Hold	2,307	–	–	0.01%	298
2025 Q4	$117K	Hold	2,307	–	–	0.02%	248
2025 Q3	$128K	Sell	2,307 -2,213	-49%	-$130K	0.02%	232
2025 Q2	$312K	Buy	4,520 +270	+6%	+$18.4K	0.06%	161
2025 Q1	$295K	Buy	4,250 +1,469	+53%	+$121K	0.06%	158
2024 Q4	$239K	Buy	2,781 +1,000	+56%	+$108K	0.04%	180
2024 Q3	$213K	Sell	1,781 -148	-8%	-$19.7K	0.04%	182
2024 Q2	$275K	Buy	1,929 +882	+84%	+$117K	0.06%	147
2024 Q1	$134K	Buy	1,047 +307	+41%	+$36.5K	0.03%	182
2023 Q4	$76.6K	Hold	740	–	–	0.02%	221
2023 Q3	$67.3K	Hold	740	–	–	0.02%	223
2023 Q2	$59.9K	Hold	740	–	–	0.02%	239
2023 Q1	$58.9K	Hold	740	–	–	0.02%	244
2022 Q4	$50K	Hold	740	–	–	0.02%	241
2022 Q3	$37K	Hold	740	–	–	0.01%	266
2022 Q2	$41K	Hold	740	–	–	0.01%	269
2022 Q1	$41K	Hold	740	–	–	0.01%	283
2021 Q4	$41K	Hold	740	–	–	0.01%	273
2021 Q3	$36K	Hold	740	–	–	0.01%	284
2021 Q2	$31K	Hold	740	–	–	0.01%	299
2021 Q1	$25K	Sell	740 -2,400	-76%	-$85.5K	0.01%	305
2020 Q4	$110K	Hold	3,140	–	–	0.04%	190
2020 Q3	$109K	Hold	3,140	–	–	0.04%	176
2020 Q2	$102K	Buy	3,140 +740	+31%	+$23.6K	0.03%	208
2020 Q1	$72K	Hold	2,400	–	–	0.03%	207
2019 Q4	$69K	Hold	2,400	–	–	0.03%	214
2019 Q3	$61K	Hold	2,400	–	–	0.03%	190
2019 Q2	$61K	Hold	2,400	–	–	0.04%	201
2019 Q1	$62K	Hold	2,400	–	–	0.04%	180
2018 Q4	$55K	Buy	+2,400	New	+$53.3K	0.05%	154

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Princeton Global Asset Management's NVO Position: Q2 2026 in Review

Princeton Global Asset Management reduced its Novo Nordisk (NVO) stake by 32% in Q2 2026, selling an estimated $31.5K and leaving 1,573 shares worth $75.4K. The position accounts for 0.01% of the portfolio, ranked #321.

Princeton Global Asset Management first reported a position in NVO in Q4 2018 and has held it in 31 quarters since. The position peaked at $312K in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Princeton Global Asset Management held 1,573 shares of Novo Nordisk worth $75.4K as of Q2 2026.
Princeton Global Asset Management sold 734 Novo Nordisk shares in Q2 2026, an estimated $31.5K.
Novo Nordisk made up 0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #321 holding.
Princeton Global Asset Management first reported a position in Novo Nordisk in Q4 2018 and has held it in 31 quarters since.
Princeton Global Asset Management's Novo Nordisk position peaked at $312K in Q2 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.